Cite
HARVARD Citation
Hamfjord, J. et al. (2021). Clinicopathological factors associated with tumour‐specific mutation detection in plasma of patients with RAS‐mutated or BRAF‐mutated metastatic colorectal cancer. International journal of cancer. 149 (6), pp. 1385-1397. [Online].